title: Activated protein C resistance assay and factor V Leiden.
abstract: The authors suggest that functional testing for activated protein C resistance is cheaper and more clinically relevant than genetic testing to detect a factor V Leiden mutation in identifying persons who are at risk for thromboembolism.
authors.affiliation: Medical University of Graz, Graz, Austria.
authors.forename: Florian
authors.initials: F
authors.lastname: Prüller
authors.forename: Eva-Christine
authors.initials: EC
authors.lastname: Weiss
authors.forename: Reinhard B
authors.initials: RB
authors.lastname: Raggam
authors.forename: Mila
authors.initials: M
authors.lastname: Cervar-Zivkovic
authors.forename: Wilfried
authors.initials: W
authors.lastname: Renner
authors.forename: Jasmin
authors.initials: J
authors.lastname: Wagner
authors.forename: Simon
authors.initials: S
authors.lastname: Michaelis
authors.forename: Winfried
authors.initials: W
authors.lastname: März
authors.forename: Harald
authors.initials: H
authors.lastname: Mangge
mesh_terms: D020016:Activated Protein C Resistance / Q000175:diagnosis* / Q000235:genetics; D005165:Factor V / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D010314:Partial Thromboplastin Time / Q000191:economics; D010641:Phenotype; D017354:Point Mutation; D016133:Polymerase Chain Reaction / Q000191:economics
chemical_list: C095381:factor V Leiden; D005165:Factor V